Anne-Brita K.
- Country
- Norway
- Department
- Geriatric medicine
Research Overview
- Phase 1/2a Evaluation of Intraperitoneal α-Emitting Radionuclide Therapy in Peritoneal Carcinomatosis from Colorectal Carcinoma Post-Hyperthermic Chemotherapy
- Oral semaglutide versus placebo in early Alzheimer’s disease: a randomized double-blind trial in patients with mild cognitive impairment or mild dementia
- Phase IIa Multicenter RCT on Ambroxol Efficacy in Prodromal and Mild Dementia with Lewy Bodies
Data & Insights
Has run more than one trial at 42 of 131 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in treating patients with colorectal carcinoma and its advanced manifestations, particularly focusing on cases involving peritoneal carcinomatosis.
- Colorectal Cancer Management
- Peritoneal Surface Malignancies
- Advanced Metastatic Disease
The investigator's work encompasses innovative therapeutic approaches for peritoneal surface oncology.
Surgical Oncology
Key expertise includes cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for treating peritoneal malignancies.
- Complex Surgical Procedures
- Multimodal Treatment Approaches
- Peritoneal Surface Surgery
The investigator utilizes advanced surgical techniques integrated with novel therapeutic strategies.
Innovative Therapeutics
The investigator explores radionuclide-based therapies for treating peritoneal carcinomatosis, including the evaluation of novel intraperitoneal treatments.
- Targeted Radiotherapy
- Intraperitoneal Treatments
- Therapeutic Innovation
Focus includes the development of new treatment modalities for peritoneal malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.